Latest Prometheus Laboratories Inc. Stories
Analyses of PROCLAIM Patient Registry Data Suggest a Therapy-Enhancing Role with Checkpoint Inhibitors for Patients with mM, and Relevant First-Line Option for Patients with mRCC SAN DIEGO,
Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/
Retrospective Analysis Demonstrates Survival Benefits for Patients with Stable and Progressive Disease after HD IL-2 in the Modern Era Suggesting Appropriate Drug Sequencing May Improve Outcomes
- A handkerchief.
- In general, any miraculous portrait of Christ.